Chester Whitley
Professor, Division of Pediatric Genetics & Metabolism · University of Minnesota
Credentials: · · · · ·
History
- Present
- 1980–1983
Pediatrics
Research
Agalsidase-beta therapy for advanced Fabry disease: a randomized trial
Annals of Internal Medicine · 2007 · 450 citations
The Lancet · 2007 · 248 citations
Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
The Journal of Pediatrics · 2004 · 204 citations
20 papers
19 papers
- KD
16 papers
14 papers
11 papers
10 papers
- LP
10 papers
9 papers
Grants
- 2009–2025
National Institute of Neurological Disorders and Stroke · U54
Contact PI · $17.7M · University of Minnesota
- 1995–2017
Gene Therapy for Metabolic Disorders
National Institute of Child Health and Human Development · P01
Contact PI · $18.1M · University of Minnesota
- 2013–2014
The Lysosomal Disease Network's 10th Annual WORLD Symposium
National Institute of Neurological Disorders and Stroke · R13
Contact PI · $35K · University of Minnesota
- 2012–2013
Lysosomal Disease Network-9th Annual WORLD Symposium
National Institute of Neurological Disorders and Stroke · R13
Contact PI · $28.3K · University of Minnesota
Clinical trials
- 2014–2016
Principal investigator · Completed · Phase 3
Ultragenyx Pharmaceutical Inc
- 2010–2014
- 2009–2019
Longitudinal Studies of Brain Structure and Function in MPS Disorders
Principal investigator · Completed
University of Minnesota
- 2009–2016
Principal investigator · Completed
University of Chicago